“…Thus, HA is biocompatible, biodegradable, and nontoxic and has smart biodistribution and natural targeting ability, e.g., for CD44 receptors; also, HA-derived micro/nanogels have modifiable surface chemistry and morphology. , The chemical structure of HA, consisting of d -glucuronic acid and N -acetyl- d -glucosamine repeating disaccharide units, is suitable for conjugation reactions with various drug molecules through hydroxyl or carboxylic acid groups . The use of HA and HA-based materials in ophthalmological applications is very appealing because of their inherent properties such as intraocular safety, improved biocompatibility of carrier materials, enhancement of corneal and conjunctival cell proliferation and epithelium healing, as well as use for the treatment of dry eyes and abundant presence in tear fluid and vitreous humor. , Therefore, HA micro/nanogels can be further utilized as a more effective treatment avenue for ocular delivery. , Drug carrying vehicles can be designed as sustainable release systems providing slow and long-term active agent release functioning over time by making use of chemical and physical interactions between drug molecules and polymeric networks . To generate these types of carrier systems, three main drug-loading processes of adsorption, conjugation, and encapsulation have been utilized. , Especially, chemical linking (i.e., conjugation) and entrapment (i.e., encapsulation) of drugs in polymeric networks provide more advantages such as increased drug-loading capacity, improved drug solubility and bioavailability, boosted drug release amounts, as well as slow and sustainable drug delivery periods .…”